articles

Optibiotix – on a Swiss roll now, remains a strong buy

Tom Winnifrith Saturday 23 March 2019

 

Share this

Another day, another deal. Is this No. 30 or 31, I rather lose count. But if you watched the interview with Steve O’Hara the other day, HERE, you will know that the majority of those already signed are now generating revenues and the curve in nearly all of those is sharply upwards. Optibiotix (OPTI) is profitable and hugely operationally geared.

Read the full article on ShareProphets | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Read next

Tom Winnifrith Bearcast - egg on face as BCA gets a PE bid

The big excitement today is the foiling of the plans of the Mrs to turn our cats into vegan, Guardian-reading, little darlings. I discuss that and the arrival of the tile polishing man at the Welsh hovel - photos HERE. Then I look at BCA Marketplace (BCA), Neil Woodford, Brave Bison (BBSN), Big Dish (DISH) and Dev Clever (DEV) as well as the general market frothiness.

On ShareProphets
Thursday 20 June 2019
TomWinnifrith.com Copyright © . All rights reserved.
Created by Everywhen